1449031-69-9

Upstream product

• 141699-55-0 tert-butyl 3-hydroxyazetidine-1-carboxylate 
• 111-34-2 -butyl vinyl ether 
• 1357614-51-7 tert-butyl-3-(4-bromophenyl)-3-fluoroazetidine-1-carboxylate 
• 1357614-50-6 tert-butyl 3-(4-bromophenyl )-3-hydroxyazetidine-1-carboxylate 
• 1357614-49-3 tert-butyl 3-hydroxy-3-(4-(trimethylsilyl)phenyl)azetidine-1-carboxylate 
• 398489-26-4 tert-butyl 3-oxoazetidine-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1449217-46-2 3-{4-[(Z)-3-(3,5-dichloro-phenyl)-4,4,4-trifluoro-but-2-enoyl]-phenyl}-3-fluoro-azetidine-1-carboxylic acid tert-butyl ester 
• 1449031-60-0 3-{4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-3-hydroxybutyryl]phenyl}-3-fluoroazetidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF CHIRAL ISOXAZOLINE AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS

The invention recites a chiral process for the synthesis of isoxazoline azetidine phenyl substituted derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, processes for making, and their use as a parasiticide in an animal. The variables *, R1a, R1b, R1c, R2, and R3 are as described herein

AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS

This invention recites substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in animals. The substituents A, B, R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.